BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bupivacaine liposome (Exparel) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Bupivacaine liposome (Exparel)\, from Cli
 nicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04930887-10498@assetmemo.bio
DTSTAMP:20261121T005958Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Bupivacaine liposome (Exparel): Phase 2 readout est. (NCT04930887)
DESCRIPTION:Bupivacaine liposome (Exparel)\, phase 2.\nStudy: Clinical Tria
 l of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Trea
 tment of Craniofacial Pain\nEstimated primary completion: June 2028. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/bupivacaine-liposome-expar
 el#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 4930887
URL:https://assetmemo.bio/drug/bupivacaine-liposome-exparel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
